Ishan Hirji

634 total citations
33 papers, 459 citations indexed

About

Ishan Hirji is a scholar working on Genetics, Hematology and Epidemiology. According to data from OpenAlex, Ishan Hirji has authored 33 papers receiving a total of 459 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 14 papers in Hematology and 12 papers in Epidemiology. Recurrent topics in Ishan Hirji's work include Chronic Lymphocytic Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Cytomegalovirus and herpesvirus research (10 papers). Ishan Hirji is often cited by papers focused on Chronic Lymphocytic Leukemia Research (13 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Cytomegalovirus and herpesvirus research (10 papers). Ishan Hirji collaborates with scholars based in United States, Germany and United Kingdom. Ishan Hirji's co-authors include Andres Gomez‐Caminero, Zhenchao Guo, Susan W. Andersson, Niklas Hammar, Catherine Davis, Marianne Ulcickas Yood, Colin Anderson‐Smits, Susan A. Oliveria, Mark J. Cziraky and Giovanna Devercelli and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Ishan Hirji

32 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ishan Hirji United States	9	139	125	124	117	99	33	459
Kundan Mishra India	10	52 0.4×	186 1.5×	67 0.5×	66 0.6×	11 0.1×	88	412
Richa Gupta India	12	87 0.6×	174 1.4×	66 0.5×	14 0.1×	32 0.3×	57	497
Elrazi Ali Qatar	10	51 0.4×	86 0.7×	29 0.2×	52 0.4×	28 0.3×	57	294
Sadie M. Marden United Kingdom	5	37 0.3×	43 0.3×	278 2.2×	73 0.6×	21 0.2×	6	514
Jens Helby Denmark	9	45 0.3×	52 0.4×	103 0.8×	16 0.1×	20 0.2×	21	425
Leigh Morrison United Kingdom	9	273 2.0×	104 0.8×	20 0.2×	15 0.1×	110 1.1×	17	535
Noha Irani‐Hakime Lebanon	13	28 0.2×	156 1.2×	96 0.8×	58 0.5×	73 0.7×	24	518
J. Miller United States	18	46 0.3×	69 0.6×	139 1.1×	128 1.1×	26 0.3×	101	1.1k
Nutan Agarwal India	14	22 0.2×	46 0.4×	83 0.7×	44 0.4×	33 0.3×	37	514
Christina Price United States	12	29 0.2×	28 0.2×	90 0.7×	35 0.3×	71 0.7×	27	652

Countries citing papers authored by Ishan Hirji

Since Specialization

Citations

This map shows the geographic impact of Ishan Hirji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ishan Hirji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ishan Hirji more than expected).

Fields of papers citing papers by Ishan Hirji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ishan Hirji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ishan Hirji. The network helps show where Ishan Hirji may publish in the future.

Co-authorship network of co-authors of Ishan Hirji

This figure shows the co-authorship network connecting the top 25 collaborators of Ishan Hirji. A scholar is included among the top collaborators of Ishan Hirji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ishan Hirji. Ishan Hirji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Longworth, Louise, Yemi Oluboyede, Peter Cain, et al.. (2024). A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance. Health and Quality of Life Outcomes. 22(1). 24–24. 3 indexed citations

Dobrer, Sabina, Karen Sherwood, Ishan Hirji, et al.. (2024). Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation. Frontiers in Immunology. 14. 1302627–1302627. 6 indexed citations

Hirji, Ishan, et al.. (2023). Healthcare resource utilization of maribavir versus investigator‐assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior treatment: Exploratory analysis of the Phase 3 SOLSTICE trial. Transplant Infectious Disease. 25(3). e14064–e14064. 4 indexed citations

Bassel, Marielle, et al.. (2023). Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation. Antiviral Therapy. 28(5). 211921191–211921191. 2 indexed citations

Hirji, Ishan, et al.. (2022). Healthcare Resource Utilization in Transplant Recipients with Cytomegalovirus Infection Refractory/Resistant to Treatment Receiving Maribavir Versus Investigator Assigned Therapy: Exploratory Analysis of a Phase 3 Trial. Transplantation and Cellular Therapy. 28(3). S45–S46. 1 indexed citations

Hirji, Ishan, et al.. (2022). PCR122 A Time Trade-Off Study to Determine Health-State Utilities of Transplant Recipients with Resistant or Refractory Cytomegalovirus. Value in Health. 25(7). S564–S564.

Cheng, Wendy Y., Robin K. Avery, Philippe Thompson‐Leduc, et al.. (2022). Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation. Journal of Medical Economics. 25(1). 367–380. 7 indexed citations

Mendívil, Joan, Ellen M. Janssen, Henrik Balle Boysen, et al.. (2021). Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey. Orphanet Journal of Rare Diseases. 16(1). 94–94. 44 indexed citations

Kovács, Gábor G., Giovanna Devercelli, Tamás Zelei, et al.. (2020). Association between transplant glomerulopathy and graft outcomes following kidney transplantation: A meta-analysis. PLoS ONE. 15(4). e0231646–e0231646. 8 indexed citations

10.

Augustine, Titus, John S. Gill, Klemens Budde, et al.. (2019). INTERNATIONAL, MATCHED-COHORT CHECKERBOARD STUDY OF QUALITY OF LIFE AND DISEASE BURDEN IN KIDNEY TRANSPLANT (TX) PATIENTS WITH ANTIBODY-MEDIATED REJECTION (AMR). Transplant International. 32. 310–310. 1 indexed citations

11.

Szabo, Shelagh M., Ishan Hirji, Karissa Johnston, A. Juarez-Garcia, & Joseph M. Connors. (2017). Treatment patterns and costs of care for patients with relapsed and refractory Hodgkin lymphoma treated with brentuximab vedotin in the United States: A retrospective cohort study. PLoS ONE. 12(10). e0180261–e0180261. 11 indexed citations

12.

Potluri, Ravi, et al.. (2015). Treatment Sequencing Patterns And Costs of Care in Patients with Relapsed/Refractory Multiple Myeloma. Value in Health. 18(7). A450–A450. 3 indexed citations

13.

Quinn, Casey, et al.. (2015). Mapping Health State Utility Values From Eortc Data Collected From A Clinical Trial Population With Relapsed/Refractory Multiple Myeloma. Value in Health. 18(7). A468–A468. 1 indexed citations

14.

Cortes, Jörge E., Rüdiger Hehlmann, Carlo Gambacorti‐Passerini, et al.. (2013). Baseline Characteristics Of Patients With Chronic Myeloid Leukemia In a Prospective Observational Study (SIMPLICITY). Blood. 122(21). 4026–4026. 4 indexed citations

15.

Hirji, Ishan, Shaloo Gupta, Amir Goren, et al.. (2013). Chronic myeloid leukemia (CML): association of treatment satisfaction, negative medication experience and treatment restrictions with health outcomes, from the patient’s perspective. Health and Quality of Life Outcomes. 11(1). 167–167. 40 indexed citations

16.

Hirji, Ishan, Susan W. Andersson, Zhenchao Guo, Niklas Hammar, & Andres Gomez‐Caminero. (2012). Incidence of genital infection among patients with type 2 diabetes in the UK General Practice Research Database. Journal of Diabetes and its Complications. 26(6). 501–505. 75 indexed citations

17.

Hirji, Ishan, Zhenchao Guo, Susan W. Andersson, Niklas Hammar, & Andres Gomez‐Caminero. (2012). Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD). Journal of Diabetes and its Complications. 26(6). 513–516. 134 indexed citations

18.

Gupta, Shaloo, Amir Goren, Timothy W. Victor, et al.. (2011). Associations Between Treatment Restrictions, Patient-Reported Treatment Burden and Adherence to Tyrosine-Kinase Inhibitor Therapy Among Chronic Myeloid Leukemia Patients in the United States and Europe. Blood. 118(21). 2077–2077. 1 indexed citations

19.

Cortes, Jörge E., Michael J. Mauro, Stuart L. Goldberg, et al.. (2011). Quality of Life During Early Tyrosine Kinase Inhibitor Treatment As Self-Reported by Chronic Myeloid Leukemia Patients Participating in a Prospective Observational Study (SIMPLICITY). Blood. 118(21). 4435–4435. 5 indexed citations

20.

Yood, Marianne Ulcickas, et al.. (2011). Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients (pts) with chronic myeloid leukemia (CML).. Journal of Clinical Oncology. 29(15_suppl). 6589–6589. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact